{
    "code": "06023840",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06023840",
    "time": "2017-06-02 03:27:31",
    "許可證字號": "衛署醫器輸字第023840號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/08\/14",
    "發證日期": "101\/08\/14",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA00602384005",
    "中文品名": "伯瑞普樂斯抗磷脂症候群免疫球蛋白G、M、A檢驗試劑組",
    "英文品名": "BioPlex 2200 APLS IgG, IgM, IgA",
    "效能": "BioPlex2200 APLS IgG、IgM及IgA試劑是一種多重流動免疫分析法，搭配Bio-Rad BioPlex 2200系統供人類血清與經肝素或檸檬酸鹽處理的血漿中，心磷脂(CL)與乙二型糖蛋白I(β2GPI)IgG、IgM及IgA抗體之半定量檢測。",
    "醫器規格": "665-1950(100 tests\/pack), 665-2050(100 tests\/pack), 665-2150(100 tests\/pack), 663-1930(6x1.5ml), 663-2030(6x1.5ml), 663-2130(6x1.5ml), 663-1900(7x0.5ml), 663-2000(7x0.5ml),663-2100(3x0.5ml),以下空白",
    "劑型": "",
    "包裝": "",
    "標籤、仿單及包裝加註": "",
    "": "",
    "醫器主類別一": "C免疫學及微生物學裝置",
    "醫器次類別一": "C5660多發性自體抗體免疫試驗系統",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "主成分略述": [
        ""
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "0939801100  美商伯瑞股份有限公司台灣分公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "M461755000  BIO-RAD LABORATORIES, INC.",
        "製造廠廠址": "14620 Ne North Woodinville Way, Woodinville, WA 98072, USA",
        "製造廠公司地址": "",
        "": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "060238400002___20121004.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06023840&Seq=002&Type=9"
        },
        {
            "title": "060238400001___20121004.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06023840&Seq=001&Type=9"
        },
        {
            "title": "060238400001___20121004.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06023840&Seq=001&Type=8"
        }
    ]
}